| Comprehensive molecular portraits of human breast tumours Brigham & Women’s Hospital & Harvard Medical School Chin Lynda 9 11 Park ... Nature 490 (7418), 61-70, 2012 | 11457 | 2012 |
| Comprehensive molecular characterization of human colon and rectal cancer Cancer Genome Atlas Network Nature 487 (7407), 330, 2012 | 7737 | 2012 |
| The cancer genome atlas pan-cancer analysis project JN Weinstein, EA Collisson, GB Mills, KR Shaw, BA Ozenberger, K Ellrott, ... Nature genetics 45 (10), 1113-1120, 2013 | 7076 | 2013 |
| The somatic genomic landscape of glioblastoma CW Brennan, RGW Verhaak, A McKenna, B Campos, H Noushmehr, ... cell 155 (2), 462-477, 2013 | 5239 | 2013 |
| Comprehensive genomic characterization of squamous cell lung cancers Cancer Genome Atlas Research Network Nature 489 (7417), 519, 2012 | 3788 | 2012 |
| Genomic classification of cutaneous melanoma R Akbani, KC Akdemir, B áArman Aksoy, M Albert, A Ally, SB Amin, ... Cell 161 (7), 1681-1696, 2015 | 2822 | 2015 |
| Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer A Kapoor, W Yao, H Ying, S Hua, A Liewen, Q Wang, Y Zhong, CJ Wu, ... Cell 158 (1), 185-197, 2014 | 747 | 2014 |
| SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression Z Ding, CJ Wu, GC Chu, Y Xiao, D Ho, J Zhang, SR Perry, ES Labrot, ... Nature 470 (7333), 269-273, 2011 | 559 | 2011 |
| Targeting YAP-dependent MDSC infiltration impairs tumor progression G Wang, X Lu, P Dey, P Deng, CC Wu, S Jiang, Z Fang, K Zhao, ... Cancer discovery 6 (1), 80-95, 2016 | 520 | 2016 |
| Type I collagen deletion in αSMA+ myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer Y Chen, J Kim, S Yang, H Wang, CJ Wu, H Sugimoto, VS LeBleu, ... Cancer cell 39 (4), 548-565. e6, 2021 | 395 | 2021 |
| Telomerase reactivation following telomere dysfunction yields murine prostate tumors with bone metastases Z Ding, CJ Wu, M Jaskelioff, E Ivanova, M Kost-Alimova, A Protopopov, ... Cell 148 (5), 896-907, 2012 | 260 | 2012 |
| Comprehensive T cell repertoire characterization of non-small cell lung cancer A Reuben, J Zhang, SH Chiou, RM Gittelman, J Li, WC Lee, J Fujimoto, ... Nature communications 11 (1), 603, 2020 | 190 | 2020 |
| TCR repertoire intratumor heterogeneity in localized lung adenocarcinomas: an association with predicted neoantigen heterogeneity and postsurgical recurrence A Reuben, R Gittelman, J Gao, J Zhang, EC Yusko, CJ Wu, R Emerson, ... Cancer discovery 7 (10), 1088-1097, 2017 | 190 | 2017 |
| Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer MV Negrao, F Skoulidis, M Montesion, K Schulze, I Bara, V Shen, H Xu, ... Journal for immunotherapy of cancer 9 (8), 2021 | 179 | 2021 |
| Proinvasion metastasis drivers in early-stage melanoma are oncogenes KL Scott, C Nogueira, TP Heffernan, R van Doorn, S Dhakal, JA Hanna, ... Cancer cell 20 (1), 92-103, 2011 | 166 | 2011 |
| Why is melanoma so metastatic? RR Braeuer, IR Watson, CJ Wu, AK Mobley, T Kamiya, E Shoshan, ... Pigment cell & melanoma research 27 (1), 19-36, 2014 | 161 | 2014 |
| Oncogenic collagen I homotrimers from cancer cells bind to α3β1 integrin and impact tumor microbiome and immunity to promote pancreatic cancer Y Chen, S Yang, J Tavormina, D Tampe, M Zeisberg, H Wang, ... Cancer cell 40 (8), 818-834. e9, 2022 | 145 | 2022 |
| ILF2 is a regulator of RNA splicing and DNA damage response in 1q21-amplified multiple myeloma M Marchesini, Y Ogoti, E Fiorini, AA Samur, L Nezi, M D'Anca, P Storti, ... Cancer cell 32 (1), 88-100. e6, 2017 | 144 | 2017 |
| Neoantigen responses, immune correlates, and favorable outcomes after ipilimumab treatment of patients with prostate cancer SK Subudhi, L Vence, H Zhao, J Blando, SS Yadav, Q Xiong, A Reuben, ... Science translational medicine 12 (537), eaaz3577, 2020 | 137 | 2020 |
| microRNA regulatory network inference identifies miR-34a as a novel regulator of TGF-β signaling in glioblastoma G Genovese, A Ergun, SA Shukla, B Campos, J Hanna, P Ghosh, ... Cancer discovery 2 (8), 736-749, 2012 | 126 | 2012 |
